Minor-clone TP53 mutations in CLL patients entering first-line treatment: clonal evolution and clinical impact.

Investor logo
Investor logo

Warning

This publication doesn't include Faculty of Sports Studies. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Authors

MALČÍKOVÁ Jitka PAVLOVÁ Šárka VONKOVÁ Barbara KOTAŠKOVÁ Jana RADOVÁ Lenka PLEVOVÁ Karla ŽENATOVÁ Marcela HYNŠT Jakub DVOŘÁČKOVÁ Barbara PANOVSKÁ Anna BRYCHTOVÁ Yvona TICHÝ Boris TOM Nikola PÁL Karol MAYER Jiří DOUBEK Michael POSPÍŠILOVÁ Šárka

Year of publication 2020
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Description Aims • To assess the risk of clonal expansion of minor-clone TP53 mutations • To evaluate the clinical impact of TP53 mutations with different variant allele frequencies (VAFs) ...in patients entering first-line treatment
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info